Liliana Ostopovici-Halip
Liliana Ostopovici-Halip
The Institute of Chemistry, Timisoara
Verifierad e-postadress på acad-icht.tm.edu.ro
Citeras av
Citeras av
Modulation of bitter taste perception by a small molecule hTAS2R antagonist
JP Slack, A Brockhoff, C Batram, S Menzel, C Sonnabend, S Born, ...
Current Biology 20 (12), 1104-1109, 2010
WOMBAT: world of molecular bioactivity
M Olah, M Mracec, L Ostopovici, R Rad, A Bora, N Hadaruga, I Olah, ...
Chemoinformatics in drug discovery 223239, 2004
DrugCentral 2021 supports drug discovery and repositioning
S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ...
Nucleic acids research 49 (D1), D1160-D1169, 2021
A crowdsourcing evaluation of the NIH chemical probes
TI Oprea, CG Bologa, S Boyer, RF Curpan, RC Glen, AL Hopkins, ...
Nature chemical biology 5 (7), 441-447, 2009
Lead-like, drug-like or “Pub-like”: how different are they?
TI Oprea, TK Allu, DC Fara, RF Rad, L Ostopovici, CG Bologa
Journal of Computer-Aided Molecular Design 21, 113-119, 2007
WOMBAT and WOMBAT‐PK: bioactivity databases for lead and drug discovery
M Olah, R Rad, L Ostopovici, A Bora, N Hadaruga, D Hadaruga, ...
Chemical biology: from small molecules to systems biology and drug design 1 …, 2007
Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation
A Chigaev, A Waller, O Amit, L Halip, CG Bologa, LA Sklar
Journal of Biological Chemistry 284 (21), 14337-14346, 2009
Structural determinants of the alpha2 adrenoceptor subtype selectivity
L Ostopovici-Halip, R Curpăn, M Mracec, CG Bologa
Journal of Molecular Graphics and Modelling 29 (8), 1030-1038, 2011
Conformational mAb as a tool for integrin ligand discovery
BH Njus, A Chigaev, A Waller, D Wlodek, L Ostopovici-Halip, O Ursu, ...
Assay and drug development technologies 7 (5), 507-515, 2009
FRET detection of lymphocyte function–associated antigen-1 conformational extension
A Chigaev, Y Smagley, MK Haynes, O Ursu, CG Bologa, L Halip, T Oprea, ...
Molecular biology of the cell 26 (1), 43-54, 2015
DrugCentral 2023 extends human clinical data and integrates veterinary drugs
S Avram, TB Wilson, R Curpan, L Halip, A Borota, A Bora, CG Bologa, ...
Nucleic acids research 51 (D1), D1276-D1287, 2023
Modeling kinase inhibition using highly confident data sets
S Avram, A Bora, L Halip, R Curpan
Journal of Chemical Information and Modeling 58 (5), 957-967, 2018
On the propagation of errors in the QSAR literature
TI Oprea, M Olah, L Ostopovici, R Rad, M Mracec
EuroQSAR, 314-315, 2002
Three small molecule pan activator families of Ras-related GTPases
Z Surviladze, O Ursu, F Miscioscia, R Curpan, L Halip, C Bologa, T Oprea, ...
Probe Reports from the NIH Molecular Libraries Program [Internet], 2010
Off-patent drug repositioning
S Avram, R Curpan, L Halip, A Bora, TI Oprea
Journal of chemical information and modeling 60 (12), 5746-5753, 2020
Novel drug targets in 2021
S Avram, L Halip, R Curpan, TI Oprea
Nat Rev Drug Discov 21 (5), 328-9, 2022
Novel drug targets in 2019.
S Avram, L Halip, R Curpan, TI Oprea
Nature Reviews Drug Discovery 19 (5), 300-301, 2020
Synthesis, structure and toxicity evaluation of ethanolamine nitro/chloronitrobenzoates: a combined experimental and theoretical study
M Crisan, L Halip, P Bourosh, SA Chicu, Y Chumakov
Chemistry Central Journal 11, 1-10, 2017
A QSAR study using MTD method and Dragon descriptors for a series of selective ligands of α2C adrenoceptor
A Borota, M Mracec, A Gruia, R Rad-Curpăn, L Ostopovici-Halip, ...
European journal of medicinal chemistry 46 (3), 877-884, 2011
Exploring the binding site of the human muscarinic M3 Receptor: homology modeling and docking study
L Ostopovici, M Mracec, M Mracec, A Borota
International Journal of Quantum Chemistry 107 (8), 1794-1802, 2007
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20